Law360
Tyson Provides Road Map For Use Of Sampling In FCA Cases
March 31, 2016
The circumstances under which statistical sampling can be used in order to establish liability in False Claims Act cases remains a controversial issue. Defendants argue that sampling results in a “trial by formula” that can result in ruinous liability based on evidence relating to a relatively small number of claims, while the U.S. Department of Justice and relators’ counsel argue that statistical sampling is an accepted form of evidence, and that limiting its use in FCA cases would have the perverse effect of immunizing the largest frauds from the full scope of liability.
Contacts
Capabilities
Suggested News & Insights
District of Massachusetts Rejects Per Se AKS Liability for Commissioned, Independent Contractor Sales Representatives But Allows FCA Claims to ProceedOctober 26, 2026DOJ Launches Criminal and Civil Self-Disclosure Programs Relevant to Healthcare and Life Sciences CompaniesOctober 26, 2026DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot Program with Fixed Repayment MultiplierOctober 22, 2026HHS Secretary Extends HHS-OIG Exclusion Authority to CMS, Expanding the Administration's Anti-Fraud CampaignOctober 19, 2026DOJ Fraud Division and HHS-OIG Announce Joint Self-Disclosure Policy, Directing Healthcare Companies to Bring Potential Criminal Matters to DOJ FirstOctober 16, 2026Court Grants Summary Judgment in Kickback-Based FCA Case, Holding Relator Failed to Prove Remuneration or WillfulnessOctober 7, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
